Alba funding

Edinburgh-based Alba Bioscience has announced funding to create 16 new research and development jobs and develop novel technologies in life science diagnostics.

The company’s investment includes a £1.8m R and D grant from RDA Scottish Enterprise.

John Allan, chief executive officer at Alba Bioscience, said: ‘Some of the key factors of this award will be the creation and safeguarding of new research and development jobs, which will enhance our current scientific skills base and assist our growth.

‘This strengthens the company’s contribution to the economy locally and in the development of Scotland’s expertise in the life science arena.’

Alba Bioscience manufactures diagnostic reagents and is one of the largest manufacturers of monoclonal blood grouping products in the world, with over 70 per cent of orders coming from overseas.

Its product range also includes contract manufacturing services in cryo preservation, freeze drying and antibody production.

The company was privatised from the NHS and received Food and Drug Administration clearance last year to sell some of its products in the US.